Literature DB >> 31752738

Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017.

Simona Puzelli1, Angela Di Martino2, Marzia Facchini2, Concetta Fabiani2, Laura Calzoletti2, Giuseppina Di Mario2, Annapina Palmieri2, Paola Affanni3, Barbara Camilloni4, Maria Chironna5, Pierlanfranco D'Agaro6, Simone Giannecchini7, Elena Pariani8, Caterina Serra9, Caterina Rizzo2, Antonino Bella2, Isabella Donatelli2, Maria Rita Castrucci2.   

Abstract

BACKGROUND: Since 1985, two antigenically distinct lineages of influenza B viruses (Victoria-like and Yamagata-like) have circulated globally. Trivalent seasonal influenza vaccines contain two circulating influenza A strains but a single B strain and thus provide limited immunity against circulating B strains of the lineage not included in the vaccine. In this study, we describe the characteristics of influenza B viruses that caused respiratory illness in the population in Italy over 13 consecutive seasons of virological surveillance, and the match between the predominant influenza B lineage and the vaccine B lineage, in each season.
METHODS: From 2004 to 2017, 26,886 laboratory-confirmed influenza cases were registered in Italy, of which 18.7% were type B. Among them, the lineage of 2465 strains (49%) was retrieved or characterized in this study by a real-time RT-PCR assay and/or sequencing of the hemagglutinin (HA) gene.
RESULTS: Co-circulation of both B lineages was observed each season, although in different proportions every year. Overall, viruses of B/Victoria and B/Yamagata lineages caused 53.3 and 46.7% of influenza B infections, respectively. A higher proportion of infections with both lineages was detected in children, and there was a declining frequency of B/Victoria detections with age. A mismatch between the vaccine and the predominant influenza B lineage occurred in eight out of thirteen influenza seasons under study. Considering the seasons when B accounted for > 20% of all laboratory-confirmed influenza cases, a mismatch was observed in four out of six seasons. Phylogenetic analysis of the HA1 domain confirmed the co-circulation of both lineages and revealed a mixed circulation of distinct evolutionary viral variants, with different levels of match to the vaccine strains.
CONCLUSIONS: This study contributes to the understanding of the circulation of influenza B viruses in Italy. We found a continuous co-circulation of both B lineages in the period 2004-2017, and determined that children were particularly vulnerable to Victoria-lineage influenza B virus infections. An influenza B lineage mismatch with the trivalent vaccine occurred in about two-thirds of cases.

Entities:  

Keywords:  Influenza B virus; Influenza virological surveillance; Italy; Vaccine match; Victoria lineage; Yamagata lineage

Year:  2019        PMID: 31752738     DOI: 10.1186/s12879-019-4621-z

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  12 in total

Review 1.  Influenza B: Prospects for the Development of Cross-Protective Vaccines.

Authors:  Liudmila M Tsybalova; Liudmila A Stepanova; Edward S Ramsay; Andrey V Vasin
Journal:  Viruses       Date:  2022-06-17       Impact factor: 5.818

Review 2.  Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines.

Authors:  Claudia Maria Trombetta; Otfried Kistner; Emanuele Montomoli; Simonetta Viviani; Serena Marchi
Journal:  Vaccines (Basel)       Date:  2022-05-01

Review 3.  Reverse genetics for influenza B viruses and recent advances in vaccine development.

Authors:  Stivalis Cardenas-Garcia; C Joaquin Caceres; Daniela Rajao; Daniel R Perez
Journal:  Curr Opin Virol       Date:  2020-11-27       Impact factor: 7.090

4.  Immunity status against tetanus in young migrants: a seroprevalence study.

Authors:  Paola Affanni; Maria Eugenia Colucci; Emanuela Capobianco; Maria Teresa Bracchi; Roberta Zoni; Isabella Viani; Luca Caruso; Lucrezia Carlone; Carlo Arcuri; Licia Veronesi
Journal:  Acta Biomed       Date:  2020-04-10

5.  Influenza vaccine effectiveness in children: a retrospective study on eight post-pandemic seasons with trivalent inactivated vaccine.

Authors:  Maria Eugenia Colucci; Paola Affanni; Angelo Cantarelli; Luca Caruso; Maria Teresa Bracchi; Emanuela Capobianco; Roberta Zoni; Giulia Paini; Anna Odone; Mostafa Mohieldin Mohieldin Mahgoub Ibrahim; Licia Veronesi
Journal:  Acta Biomed       Date:  2020-04-10

6.  Characterizing the transmission patterns of seasonal influenza in Italy: lessons from the last decade.

Authors:  Caterina Rizzo; Stefano Merler; Marco Ajelli; Filippo Trentini; Elena Pariani; Antonino Bella; Giulio Diurno; Lucia Crottogini
Journal:  BMC Public Health       Date:  2022-01-06       Impact factor: 3.295

7.  An exploratory study to assess patterns of influenza- and pneumonia-related mortality among the Italian elderly.

Authors:  Elettra Fallani; Andrea Orsi; Alessio Signori; Giancarlo Icardi; Alexander Domnich
Journal:  Hum Vaccin Immunother       Date:  2021-12-29       Impact factor: 3.452

8.  Spread of Respiratory Pathogens During the COVID-19 Pandemic Among Children in the Northeast of Italy.

Authors:  Carolina Cason; Giulia Zamagni; Giorgio Cozzi; Davide Tonegutto; Luca Ronfani; Chiara Oretti; Andrea De Manzini; Egidio Barbi; Manola Comar; Alessandro Amaddeo
Journal:  Front Microbiol       Date:  2022-03-24       Impact factor: 5.640

9.  Lineage-specific protection and immune imprinting shape the age distributions of influenza B cases.

Authors:  Marcos C Vieira; Celeste M Donato; Philip Arevalo; Guus F Rimmelzwaan; Timothy Wood; Liza Lopez; Q Sue Huang; Vijaykrishna Dhanasekaran; Katia Koelle; Sarah Cobey
Journal:  Nat Commun       Date:  2021-07-14       Impact factor: 14.919

10.  Viruses of Respiratory Tract: an Observational Retrospective Study on Hospitalized Patients in Rome, Italy.

Authors:  Marco Ciotti; Massimo Maurici; Viviana Santoro; Luigi Coppola; Loredana Sarmati; Gerardo De Carolis; Patrizia De Filippis; Francesca Pica
Journal:  Microorganisms       Date:  2020-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.